ORAL FACTOR XA INHIBITORS VERSUS WARFARIN FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN ADVANCED CHRONIC KIDNEY DISEASE

Oral Factor Xa Inhibitors versus Warfarin for the Treatment of Venous Thromboembolism in Advanced Chronic Kidney Disease

Introduction.Warfarin remains the preferred oral anticoagulant for the treatment of venous thromboembolism (VTE) in patients with advanced chronic kidney disease (CKD).Although the direct oral anticoagulants (DOACs) have become preferred for treatment of VTE in the general population, patients with advanced CKD were excluded from the landmark trial

read more


Toxoplasmosis infection.

Background: Toxoplasmosis is the most widespread zoonosis worldwide.Its prevalence can double in rural populations in relation to urban populations, and it is different in persons of different races within the same community.Objective: To determine the characteristics of toxoplasmosis infection in Charavalle community, Bermúdez municipality, Sucre

read more